Menu Search
Equities

XSpray Pharma AB (publ)

6XP:FRA

XSpray Pharma AB (publ)

Actions
  • Price (EUR)4.03
  • Today's Change-0.255 / -5.96%
  • Shares traded300.00
  • 1 Year change+4.01%
  • Beta--
Data delayed at least 15 minutes, as of Sep 23 2024 14:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in SEKView more

In 2023, XSpray Pharma AB (publ) increased its cash reserves by 38.39%, or 46.14m. Cash Flow from Financing totalled 315.59m or -- of revenues. In addition the company used 203.28m for operations while cash used for investing totalled 65.88m.
Cash flow per share-6.76
Price/Cash flow per share--
Book value per share19.79
Tangible book value per share6.50
More ▼

Balance sheet in SEKView more

XSpray Pharma AB (publ) has little financial risk as the capital structure does not rely on leverage.
Current ratio4.67
Quick ratio3.50
Total debt/total equity0.0521
Total debt/total capital0.0496
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.